PDBsum entry: 1y1b

Hydrolase inhibitor

PDB id: 1y1b

Contents

Protein chain

48 a.a. *

* Residue conservation analysis

PDB id:

1y1b

Name:

Hydrolase inhibitor

Title:

Solution structure of anemonia elastase inhibitor

Structure:

Elastase inhibitor. Chain: a. Engineered: yes

Source:

Synthetic: yes. Other_details: this sequence is modified from the sequence occuring naturally in sea anemone anemonia sulcata ((snake- locks sea anemone).

NMR struc:

20 models

Authors:

H.Hemmi,T.Kumazaki,K.Yoshizawa-Kumagaye,Y.Nishiuchi, T.Yoshida,T.Ohkubo,Y.Kobayashi

Key ref:

H.Hemmi et al. (2005). Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata. Biochemistry, 44, 9626-9636. PubMed id: 16008348 DOI: 10.1021/bi0472806

Date:

18-Nov-04 Release date: 19-Jul-05

Protein chain

P16895  (IELA_ANESU) -  Elastase inhibitor

Seq: 48 a.a.

Struc: 48 a.a.

 Gene Ontology (GO) functional annotation 

• Biochemical function: peptidase inhibitor activity (2 terms)

DOI no: 10.1021/bi0472806

Biochemistry 44:9626-9636 (2005)

PubMed id: 16008348

Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.

H.Hemmi, T.Kumazaki, K.Yoshizawa-Kumagaye, Y.Nishiuchi, T.Yoshida, T.Ohkubo, Y.Kobayashi.

ABSTRACT

Anemonia elastase inhibitor (AEI) is a "nonclassical" Kazal-type elastase inhibitor from Anemonia sulcata. Unlike many nonclassical inhibitors, AEI does not have a cystine-stabilized alpha-helical (CSH) motif in the sequence. We chemically synthesized AEI and determined its three-dimensional solution structure by two-dimensional NMR spectroscopy. The resulting structure of AEI was characterized by a central alpha-helix and a three-stranded antiparallel beta-sheet of a typical Kazal-type inhibitor such as silver pheasant ovomucoid third domain (OMSVP3), even though the first and fifth half-cystine residues forming a disulfide bond in AEI are shifted both toward the C-terminus in comparison with those of OMSVP3. Synthesized AEI exhibited unexpected strong inhibition toward Streptomyces griseus protease B (SGPB). Our demonstrated that the site-specific introduction of the engineered disulfide bond into the OMSVP3 molecule to form the CSH motif could produce an inhibitor with a narrower specificity. Thus, the CSH motif-containing derivative of AEI (AEI analogue) was chemically synthesized when a Cys(4)-Cys(34) bond was changed to a Cys(6)-Cys(31) bond. The AEI analogue scarcely inhibited porcine pancreatic elastase (PPE), even though it exhibited almost the same potent inhibitory activity toward SGPB. For the molecular scaffold, essentially no structural difference was detected between the two, but the N-terminal loop from Pro(5) to Ile(7) near the putative reactive site (Met(10)-Gln(11)) in the analogue moved by 3.7 A toward the central helix to form the introduced Cys(6)-Cys(31) bond. Such a conformational change in the restricted region correlates with the specificity change of the inhibitor.